Global Cholesterol Testing Market to Reach $31.7 Billion by 2030
The global market for Cholesterol Testing estimated at US$22 Billion in the year 2022, is projected to reach a revised size of US$31.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$11.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 4.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR
The Cholesterol Testing market in the U.S. is estimated at US$6.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.4 Billion by the year 2030.Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- AccuTech LLC
- Akers Biosciences Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Home Access Health Corporation
- Laboratory Corporation of America® Holdings
- PTS Diagnostics
- Quest Diagnostics Inc.
- Randox Laboratories Ltd.
- Sekisui Diagnostics LLC
- Siemens Healthineers
- Sigma-Aldrich Corp.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Cholesterol Testing?
What is the growth rate of the Global Market for Cholesterol Testing?
What is the forecasted size of the Global Market for Cholesterol Testing?
Who are the key companies in the Global Market for Cholesterol Testing?
Report Attribute | Details |
---|---|
No. of Pages | 273 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 22 Billion |
Forecasted Market Value ( USD | $ 31.7 Billion |
Compound Annual Growth Rate | 4.7% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- AccuTech LLC
- Akers Biosciences Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Home Access Health Corporation
- Laboratory Corporation of America® Holdings
- PTS Diagnostics
- Quest Diagnostics Inc.
- Randox Laboratories Ltd.
- Sekisui Diagnostics LLC
- Siemens Healthineers
- Sigma-Aldrich Corp.